MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors

Shivdasani, 2006, MicroRNAs: regulators of gene expression and cell differentiation., Blood, 108, 3646, 10.1182/blood-2006-01-030015 Olena, 2010, Genomic organization of microRNAs., J Cell Physiol, 222, 540 Harris, 2010, MicroRNAs as immune regulators: implications for transplantation., Am J Transplant, 10, 713, 10.1111/j.1600-6143.2010.03032.x Gurtan, 2013, The role of miRNAs in regulating gene expression networks., J Mol Biol, 425, 3582, 10.1016/j.jmb.2013.03.007 Arora, 2013, miRNA-transcription factor interactions: a combinatorial regulation of gene expression., Mol Genet Genomics, 288, 77, 10.1007/s00438-013-0734-z Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation., Science, 303, 83, 10.1126/science.1091903 Havelange, 2010, MicroRNAs: emerging key regulators of hematopoiesis., Am J Hematol, 85, 935, 10.1002/ajh.21863 Belver, 2011, MicroRNA control of lymphocyte differentiation and function., Curr Opin Immunol, 23, 368, 10.1016/j.coi.2011.02.001 Schotte, 2012, MicroRNAs in acute leukemia: from biological players to clinical contributors., Leukemia, 26, 1, 10.1038/leu.2011.151 Gordon, 2013, MicroRNAs in myeloid malignancies., Br J Haematol, 162, 162, 10.1111/bjh.12364 Akbari Moqadam, 2013, The hunting of targets: challenge in miRNA research., Leukemia, 27, 16, 10.1038/leu.2012.179 Sawyers, 1999, Chronic myeloid leukemia., N Engl J Med, 340, 1330, 10.1056/NEJM199904293401706 Venturini, 2007, Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells., Blood, 109, 4399, 10.1182/blood-2006-09-045104 Agirre, 2008, Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth., Mol Cancer Res, 6, 1830, 10.1158/1541-7786.MCR-08-0167 Eiring, 2010, miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts., Cell, 140, 652, 10.1016/j.cell.2010.01.007 Chim, 2011, Epigenetic inactivation of the hsa-miR-203 in haematological malignancies., J Cell Mol Med, 15, 2760, 10.1111/j.1582-4934.2011.01274.x Bueno, 2008, Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression., Cancer Cell, 13, 496, 10.1016/j.ccr.2008.04.018 San José-Enériz, 2009, MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations., Mol Cancer, 8, 69, 10.1186/1476-4598-8-69 Chu, 2004, BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells., Blood, 103, 3167, 10.1182/blood-2003-04-1271 Modi, 2011, Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells., Leukemia, 25, 305, 10.1038/leu.2010.257 Chu, 2007, BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia., Cancer Res, 67, 7045, 10.1158/0008-5472.CAN-06-4312 Fu, 2005, Identification of human fetal liver miRNAs by a novel method., FEBS Lett, 579, 3849, 10.1016/j.febslet.2005.05.064 Lulli, 2013, MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A., PLoS ONE, 8, e60436, 10.1371/journal.pone.0060436 Shaham, 2015, MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down Syndrome., Blood, 10.1182/blood-2014-06-581892 Rank, 2009, Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant., Blood, 113, 3352, 10.1182/blood-2008-08-172841 Gallagher, 2000, The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter., Blood, 96, 1136, 10.1182/blood.V96.3.1136.015k48_1136_1143 Lutter, 2010, Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects., BMC Genomics, 11, 224, 10.1186/1471-2164-11-224 Small, 2010, Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486., Proc Natl Acad Sci USA, 107, 4218, 10.1073/pnas.1000300107 Hitachi, 2014, Myostatin signaling regulates Akt activity via the regulation of miR-486 expression., Int J Biochem Cell Biol, 47, 93, 10.1016/j.biocel.2013.12.003 Zhang, 2006, PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention., Nature, 441, 518, 10.1038/nature04747 Zhang, 2011, Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice., Leukemia, 25, 1857, 10.1038/leu.2011.220 Kau, 2003, A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells., Cancer Cell, 4, 463, 10.1016/S1535-6108(03)00303-9 Tothova, 2007, FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress., Cell, 128, 325, 10.1016/j.cell.2007.01.003 Mansson, 2012, Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate., Proc Natl Acad Sci USA, 109, 21028, 10.1073/pnas.1211427109 Sekine, 2007, Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development., EMBO J, 26, 3607, 10.1038/sj.emboj.7601784 Mahmud, 2002, Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells., Oncogene, 21, 1556, 10.1038/sj.onc.1205230 Zhao, 2006, Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway., Blood, 107, 907, 10.1182/blood-2005-06-2516 McDonald, 2004, Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth., Proc Natl Acad Sci USA, 101, 6170, 10.1073/pnas.0307459101 Turashvili, 2007, Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis., BMC Cancer, 7, 55, 10.1186/1471-2407-7-55 Ariës, 2014, EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion., Leukemia, 28, 1828, 10.1038/leu.2014.80 Nie, 2013, Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis., J Clin Invest, 123, 5082, 10.1172/JCI67752 Namløs, 2012, Modulation of the osteosarcoma expression phenotype by microRNAs., PLoS ONE, 7, e48086, 10.1371/journal.pone.0048086 Võsa, 2013, Meta-analysis of microRNA expression in lung cancer., Int J Cancer, 132, 2884, 10.1002/ijc.27981 Oh, 2011, Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer., Clin Cancer Res, 17, 2657, 10.1158/1078-0432.CCR-10-3152 Mees, 2009, Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas., Ann Surg Oncol, 16, 2339, 10.1245/s10434-009-0531-4 Narducci, 2011, MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome., Cell Death Dis, 2, e151, 10.1038/cddis.2011.32 Ragusa, 2010, Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment., Mol Cancer Ther, 9, 3396, 10.1158/1535-7163.MCT-10-0137 Druker, 2001, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia., N Engl J Med, 344, 1031, 10.1056/NEJM200104053441401 Peng, 2010, PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice., Blood, 115, 626, 10.1182/blood-2009-06-228130